文献速递消化系统肿瘤妇科肿瘤

符合阿姆斯特丹标准的林奇综合征家族中的癌症风险

Cancer Risk in Families Fulfilling the Amsterdam Criteria for Lynch Syndrome.
PubMed 文献 · JAMA Oncol · 2017-01-01

该研究基于犹他州人群数据库,识别202个符合阿姆斯特丹I或II标准的林奇综合征家族,占全州结直肠癌的2.6%。研究通过链接犹他州癌症登记处,发现一级亲属中结直肠癌、子宫内膜癌、胃癌、小肠癌、前列腺癌、肾癌、膀胱癌、甲状腺癌和非霍奇金淋巴瘤风险显著升高,二级亲属和堂表亲中结直肠癌和子宫内膜癌风险也升高。作者认为这些数据有助于为符合阿姆斯特丹标准的家族成员提供咨询。

要点

  • 符合阿姆斯特丹标准的家族占犹他州全部结直肠癌的2.6%。
  • 一级亲属中结直肠癌SMR为10.10(95%CI 9.43-10.81),子宫内膜癌SMR为5.89(95%CI 5.09-6.78)。
  • 二级亲属和堂表亲中结直肠癌和子宫内膜癌风险也升高。

核心结论

  • 在符合阿姆斯特丹标准的家族中,观察到许多先前报道与林奇综合征相关的癌症,也发现若干先前未报道的癌症关联;一级、二级甚至三级亲属中结直肠癌和子宫内膜癌风险显著升高。
  • 本研究为临床医生提供了基于人群的无偏数据,用于咨询符合阿姆斯特丹标准的家族成员关于其癌症风险升高及癌症筛查的重要性。

研究设计与样本

  • 基于人群的研究,从犹他州人群数据库中识别202个符合阿姆斯特丹I和II标准的家族。
  • 通过链接犹他州癌症登记处,定位这些家族成员及其一级、二级和堂表亲亲属中的所有癌症诊断。
  • 研究于2016年5月1日至6月30日进行。

主要发现

  • 202个符合阿姆斯特丹标准的家族占全州所有结直肠癌的2.6%;其中59个家族同时符合阿姆斯特丹I和II标准。
  • 阿姆斯特丹标准家族的一级亲属中,结直肠癌SMR为10.10(95%CI 9.43-10.81),子宫内膜癌SMR为5.89(95%CI 5.09-6.78),胃癌SMR为2.90(95%CI 2.02-4.03),小肠癌SMR为7.72(95%CI 5.17-11.08),前列腺癌SMR为1.94(95%CI 1.73-2.17),肾癌SMR为3.22(95%CI 2.45-4.16),膀胱癌SMR为1.62(95%CI 1.22-2.12),甲状腺癌SMR为2.26(95%CI 1.55-3.17),非霍奇金淋巴瘤SMR为2.10(95%CI 1.64-2.65)。
  • 阿姆斯特丹标准家族的二级亲属中,结直肠癌SMR为4.31(95%CI 3.98-4.65),子宫内膜癌SMR为2.70(95%CI 2.30-3.14)。
  • 阿姆斯特丹标准家族的堂表亲中,结直肠癌SMR为1.85(95%CI 1.70-2.00),子宫内膜癌SMR为1.50(95%CI 1.29-1.73)。

临床怎么用

  • 作者认为,本研究为临床医生提供了基于人群的无偏数据,用于咨询符合阿姆斯特丹标准的家族成员关于其癌症风险升高及癌症筛查的重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The data describing cancer risks associated with Lynch syndrome are variable. OBJECTIVES: To quantify the prevalence of families that fulfill the Amsterdam I or II criteria for Lynch syndrome in the Utah population and investigate the risk of colonic and extracolonic cancers in family members and their relatives. DESIGN, SETTING, AND PARTICIPANTS: In a population-based study, 202 families with Amsterdam I and II criteria–positive pedigrees in the Utah Population Database were identified. Of these, all cancer diagnoses in members of families with Amsterdam criteria and their first-degree, second-degree, and first-cousin relatives were located through linkage to the Utah Cancer Registry. The study was conducted from May 1 to June 30, 2016. MAIN OUTCOMES AND MEASURES: Standardized morbidity ratios (SMRs) were estimated by comparing the observed rates of cancer in relatives with population-expected rates estimated internally from the Utah Population Database. RESULTS: A total of 202 families meeting Amsterdam criteria for Lynch syndrome accounted for 2.6% of all colorectal cancers in the state; of these, 59 met both the Amsterdam I and Amsterdam II criteria. Cancers observed in significant excess in the first-degree relatives of Amsterdam criteria pedigrees included colorectal (SMR, 10.10; 95% CI, 9.43-10.81), endometrial (SMR, 5.89; 95% CI, 5.09-6.78), stomach (SMR, 2.90; 95% CI, 2.02-4.03), small intestine (SMR, 7.72; 95% CI, 5.17-11.08), prostate (SMR, 1.94; 95% CI, 1.73-2.17), kidney (SMR, 3.22; 95% CI, 2.45-4.16), urinary bladder (SMR, 1.62; 95% CI, 1.22-2.12), thyroid (SMR, 2.26; 95% CI, 1.55-3.17), and non-Hodgkin lymphoma (SMR, 2.10; 95% CI, 1.64-2.65). Risks of colorectal and endometrial cancers were also found to be elevated in second-degree (SMR, 4.31; 95% CI, 3.98-4.65 and SMR, 2.70; 95% CI, 2.30-3.14, respectively) and first-cousin (SMR, 1.85; 95% CI, 1.70-2.00 and SMR, 1.50; 95% CI, 1.29-1.73, respectively) relatives of families with Amsterdam criteria. CONCLUSIONS AND RELEVANCE: In this population-based study of cancer risk in families fulfilling the Amsterdam criteria, many of the cancers previously reported to be associated with Lynch syndrome were observed, several previously unreported cancer associations were noted, and the risk of colorectal and endometrial cancer were markedly increased in first-, second-, and even third-degree relatives of these families. This study provides clinicians with population-based, unbiased data to counsel members of families meeting the Amsterdam criteria regarding their elevated risks of cancer and the importance of cancer screening.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Samadder NJ, Smith KR, Wong J, et al. Cancer Risk in Families Fulfilling the Amsterdam Criteria for Lynch Syndrome. JAMA Oncol. 2017. PMID: 28772302. doi:10.1001/jamaoncol.2017.0769

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。